Comprehensive Analysis of Treatment Related Morbidity and Progression -Free Survival in the GHSG Phase III HD21 Trial

P Borchmann; A Moccia; R Greil; G Schneider; MS Hertzberg; V Schaub; A Huettmann; F Keil; M Hänel; U Novak; J Meissner; A Zimmermann; S Mathas; JM Zijlstra; A Fosså; A Viardot; B Hertenstein; S Martin; P Giri; P Kamper; DL Molin; S Kreissl; J Ferdinandus; M Fuchs; A Rosenwald; W Klapper; H Eich; C Baues; M Hallek; M Dietlein; C Kobe; V Diehl

doi:10.1182/blood-2023-188720

Comprehensive Analysis of Treatment Related Morbidity and Progression -Free Survival in the GHSG Phase III HD21 Trial

P Borchmann, A Moccia, R Greil, G Schneider, MS Hertzberg, V Schaub, A Huettmann, F Keil, M Hänel, U Novak, J Meissner, A Zimmermann, S Mathas, JM Zijlstra, A Fosså, A Viardot, B Hertenstein, S Martin, P Giri, P KamperDL Molin, S Kreissl, J Ferdinandus, M Fuchs, A Rosenwald, W Klapper, H Eich, C Baues, M Hallek, M Dietlein, C Kobe, V Diehl

Universitätsklinik für Innere Medizin 3 - Hämatologie, internistische Onkologie, Hämostaseologie, Infektiologie, Rheumatologie und Onkologisches Zentrum
Universitätsklinik für Pneumologie

Publikation: Beitrag in Fachzeitschrift › publizierter Abstrakt (Zeitschrift) › Begutachtung

5 Quellenangaben (Web of Science)

Originalsprache	Englisch
Fachzeitschrift	BLOOD
Jahrgang	142
DOIs	https://doi.org/10.1182/blood-2023-188720
Publikationsstatus	Veröffentlicht - 2023
Veranstaltung	65th Annual Meeting of the American-Society-of-Hematology (ASH) - San Diego, USA/Vereinigte Staaten Dauer: 9 Dez. 2023 → 12 Dez. 2023

Zugriff auf Dokument

10.1182/blood-2023-188720

Dieses zitieren

Borchmann, P., Moccia, A., Greil, R., Schneider, G., Hertzberg, MS., Schaub, V., Huettmann, A., Keil, F., Hänel, M., Novak, U., Meissner, J., Zimmermann, A., Mathas, S., Zijlstra, JM., Fosså, A., Viardot, A., Hertenstein, B., Martin, S., Giri, P., ... Diehl, V. (2023). Comprehensive Analysis of Treatment Related Morbidity and Progression -Free Survival in the GHSG Phase III HD21 Trial. BLOOD , 142. https://doi.org/10.1182/blood-2023-188720

Borchmann, P ; Moccia, A ; Greil, R et al. / Comprehensive Analysis of Treatment Related Morbidity and Progression -Free Survival in the GHSG Phase III HD21 Trial. in: BLOOD 2023 ; Jahrgang 142.

@article{fa7572581ad84b7eb6fd04e9fc350fb7,

title = "Comprehensive Analysis of Treatment Related Morbidity and Progression -Free Survival in the GHSG Phase III HD21 Trial",

author = "P Borchmann and A Moccia and R Greil and G Schneider and MS Hertzberg and V Schaub and A Huettmann and F Keil and M H{\"a}nel and U Novak and J Meissner and A Zimmermann and S Mathas and JM Zijlstra and A Foss{\aa} and A Viardot and B Hertenstein and S Martin and P Giri and P Kamper and DL Molin and S Kreissl and J Ferdinandus and M Fuchs and A Rosenwald and W Klapper and H Eich and C Baues and M Hallek and M Dietlein and C Kobe and V Diehl",

year = "2023",

doi = "10.1182/blood-2023-188720",

language = "English",

volume = "142",

journal = "BLOOD ",

issn = "0006-4971",

publisher = "American Society of Hematology ",

note = "65th Annual Meeting of the American-Society-of-Hematology (ASH) ; Conference date: 09-12-2023 Through 12-12-2023",

}

Borchmann, P, Moccia, A, Greil, R, Schneider, G, Hertzberg, MS, Schaub, V, Huettmann, A, Keil, F, Hänel, M, Novak, U, Meissner, J, Zimmermann, A, Mathas, S, Zijlstra, JM, Fosså, A, Viardot, A, Hertenstein, B, Martin, S, Giri, P, Kamper, P, Molin, DL, Kreissl, S, Ferdinandus, J, Fuchs, M, Rosenwald, A, Klapper, W, Eich, H, Baues, C, Hallek, M, Dietlein, M, Kobe, C & Diehl, V 2023, 'Comprehensive Analysis of Treatment Related Morbidity and Progression -Free Survival in the GHSG Phase III HD21 Trial', BLOOD , Jg. 142. https://doi.org/10.1182/blood-2023-188720

Comprehensive Analysis of Treatment Related Morbidity and Progression -Free Survival in the GHSG Phase III HD21 Trial. / Borchmann, P; Moccia, A; Greil, R et al.
in: BLOOD , Jahrgang 142, 2023.

Publikation: Beitrag in Fachzeitschrift › publizierter Abstrakt (Zeitschrift) › Begutachtung

TY - JOUR

T1 - Comprehensive Analysis of Treatment Related Morbidity and Progression -Free Survival in the GHSG Phase III HD21 Trial

AU - Borchmann, P

AU - Moccia, A

AU - Greil, R

AU - Schneider, G

AU - Hertzberg, MS

AU - Schaub, V

AU - Huettmann, A

AU - Keil, F

AU - Hänel, M

AU - Novak, U

AU - Meissner, J

AU - Zimmermann, A

AU - Mathas, S

AU - Zijlstra, JM

AU - Fosså, A

AU - Viardot, A

AU - Hertenstein, B

AU - Martin, S

AU - Giri, P

AU - Kamper, P

AU - Molin, DL

AU - Kreissl, S

AU - Ferdinandus, J

AU - Fuchs, M

AU - Rosenwald, A

AU - Klapper, W

AU - Eich, H

AU - Baues, C

AU - Hallek, M

AU - Dietlein, M

AU - Kobe, C

AU - Diehl, V

PY - 2023

Y1 - 2023

U2 - 10.1182/blood-2023-188720

DO - 10.1182/blood-2023-188720

M3 - published Abstract (Journal)

SN - 0006-4971

VL - 142

JO - BLOOD

JF - BLOOD

T2 - 65th Annual Meeting of the American-Society-of-Hematology (ASH)

Y2 - 9 December 2023 through 12 December 2023

ER -

Borchmann P, Moccia A, Greil R, Schneider G, Hertzberg MS, Schaub V et al. Comprehensive Analysis of Treatment Related Morbidity and Progression -Free Survival in the GHSG Phase III HD21 Trial. BLOOD . 2023;142. doi: 10.1182/blood-2023-188720